Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

Sonia Cerquozzi, MD FRCPC, Sunita Ghosh, PhD, P.Stat., Diana Quinlan, Amy Trottier, MD, Mary Lynn Savoie, MD FRCPC, Douglas A. Stewart, MD FRCPC, James A. Russell, MD FRCPC, Carolyn Owen, MD MDes (UK), FRCPC

Blood (2015) 126 (23): 5530.

https://doi.org/10.1182/blood.V126.23.5530.5530

Published: 2015

Journal Articles

CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.

Alejandra Ugarte-Torres, MD, Yiping Liu, PhD, Tyler Williamson, Mette Hoegh-Petersen, MD, Diana Quinlan, RN, Lina Roa, Faisal Khan, PhD, James A. Russell, MD, Jan Storek, MD, PhD

Blood (2009) 114 (22): 2248.

https://doi.org/10.1182/blood.V114.22.2248.2248

Published: 2009

Journal Articles

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Pedro R. Camacho, MD-R, James Russell, MD, Karen Shepard, RN, Diana Quinlan, RN, Jan Mclaughlin, RN

Blood (2007) 110 (11): 4987.

https://doi.org/10.1182/blood.V110.11.4987.4987

Published: 2007

Journal Articles

Total Body Irradiation (TBI) Added to Fludarabine/Busulfan/Antithymocyte Gobulin (FLUBUP/ATG) Conditioning Increases Overall Survival and Relapse-Free Survival in Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Stem Cell Transplants.

Mary Lynn Savoie, MD, Alexander Balogh, MD, Ahsan Chaudhry, MD, Douglas A. Stewart, MD, Nizar J. Bahlis, MD, Jan Storek, MD,PhD, Christopher Brown, MD,PhD, Diana Quinlan, RN, Leanne Kmet, PhD, Loree M. Larratt, MD, A. Robert Turner, MD, James A. Russell, FRCPE

Blood (2006) 108 (11): 3010.

https://doi.org/10.1182/blood.V108.11.3010.3010

Published: 2006

Journal Articles

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

Farrukh Naveed, BSc, Shahbal Kangarloo, BSc, MSc, Ahsan Chaudhry, BSc, MD, Michelle Geddes, BSc, MD, Diana Quinlan, RN, BN, CCRP, James Russell, MA, MB, BChir, FRCPE

Blood (2006) 108 (11): 2941.

https://doi.org/10.1182/blood.V108.11.2941.2941

Published: 2006

Journal Articles

Once Daily IV Busulfan Given with Fludarabine in Allogeneic Stem Cell Transplantation Conditioning: High vs Low Busulfan AUC Does Not Alter Toxicities or Transplant Outcome.

Michelle Geddes, MD, Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Ahsan M. Chaudhry, MD, Oluyemi Jeje, MD, Mary L. Savoie, MD, Nizar J. Bahlis, MD, Douglas A. Stewart, MD, Christopher Brown, MD, Jan Storek, MD, PhD, Diana Quinlan, RN, Borje Andersson, MD, James A. Russell, MBBChir

Blood (2005) 106 (11): 1763.

https://doi.org/10.1182/blood.V106.11.1763.1763

Published: 2005

Journal Articles

Adult Matched Sibling Blood Cell Transplants (BCT) after Myeloablative Conditioning Incorporating Daily Intravenous (IV) Busulfan (BU) and Low-Dose Antithymocyte Globulin (ATG): Outcomes with Particular Respect to Transplant-Related Mortality (TRM) in 140 Patients.

James A. Russell, FRCP, Ahsan M. Chaudhy, MD, Oluyeme Jeje, MD, Diana Quinlan, RN, Douglas Stewart, MD, Donald Morris, MD, Nizhar J. Bahlis, MD, Lynne Savoie, MD, Christopher B. Brown, MD, Loree Larratt, MD, Michelle Geddes, MD, A. Robert Turner, MD

Blood (2004) 104 (11): 2313.

https://doi.org/10.1182/blood.V104.11.2313.2313

Published: 2004

Journal Articles

Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.

Shabal B. Kangarloo, MSc, Farrukh Naveed, BSc, Borje S. Andersson, MD, PhD, Diana Quinlan, BN, James A. Russell, FRCP

Blood (2004) 104 (11): 98.

https://doi.org/10.1182/blood.V104.11.98.98

Published: 2004

Journal Articles

Adult Recipients of Matched Related Donor Blood Cell Transplants (BCT) Given Pretransplant Low-Dose Antithymocyte Globulin (ATG) Have Less Chronic Graft-Versus-Host Disease (cGVHD) and Transplant-Related Mortality (TRM): A Matched Pair Analysis.

James A. Russell, FRCPE, A. Robert Turner, MD3, Loree Larratt, MD, Ahsan M. Chaudhry, MD, Oluyeme Jeje, MD, Don Morris, MD, Christopher B. Brown, MD, Lynne Savoie, MD, Nizhar Bahlis, MD, Diana Quinlan, RN, Douglas Stewart, MD

Blood (2004) 104 (11): 2250.

https://doi.org/10.1182/blood.V104.11.2250.2250

Published: 2004

NARROW

Myeloablative Allogeneic Stem Cell Transplantation in CLL: A Single Centre Retrospective Study

CMV-Specific Immunity and CMV Complications in Seropositive HCT Recipients Depend On Donor Serostatus.

Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.

Total Body Irradiation (TBI) Added to Fludarabine/Busulfan/Antithymocyte Gobulin (FLUBUP/ATG) Conditioning Increases Overall Survival and Relapse-Free Survival in Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Stem Cell Transplants.

Improving the Pharmacokinetic Analysis of the Once Daily IV Busulfan Regimen for Allogeneic Stem-Cell Transplants: A Scientific Method Modification.

Once Daily IV Busulfan Given with Fludarabine in Allogeneic Stem Cell Transplantation Conditioning: High vs Low Busulfan AUC Does Not Alter Toxicities or Transplant Outcome.

Adult Matched Sibling Blood Cell Transplants (BCT) after Myeloablative Conditioning Incorporating Daily Intravenous (IV) Busulfan (BU) and Low-Dose Antithymocyte Globulin (ATG): Outcomes with Particular Respect to Transplant-Related Mortality (TRM) in 140 Patients.

Individualized Once-Daily Dosing of Intravenous Busulfan: A Pharmacokinetic Study in Patients Undergoing Conditioning for Allogeneic Stem Cell Transplantation.

Adult Recipients of Matched Related Donor Blood Cell Transplants (BCT) Given Pretransplant Low-Dose Antithymocyte Globulin (ATG) Have Less Chronic Graft-Versus-Host Disease (cGVHD) and Transplant-Related Mortality (TRM): A Matched Pair Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only